Suzan M. Hammond, Ph.D.
Affiliations: | 2010 | Integrated Graduate Program in the Life Sciences | Northwestern University, Evanston, IL |
Area:
Molecular Neuroscience, Motor Control, Neurobiology of DiseaseGoogle:
"Suzan Hammond"Mean distance: 35622
Parents
Sign in to add mentor| Christine Didonato | grad student | 2010 | Northwestern | |
| (Characterizing the effect of mutations within exon 7 of the murine survival motor neuron gene to model spinal muscular atrophy in the mouse.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hammond SM, Abendroth F, Goli L, et al. (2022) Antibody-oligonucleotide conjugate achieves central nervous system delivery in animal models for spinal muscular atrophy. Jci Insight |
| Winkelsas AM, Grunseich C, Harmison GG, et al. (2021) Targeting the 5' untranslated region of as a therapeutic strategy for spinal muscular atrophy. Molecular Therapy. Nucleic Acids. 23: 731-742 |
| Ahlskog N, Hayler D, Krueger A, et al. (2020) Muscle overexpression of Klf15 via an AAV8-Spc5-12 construct does not provide benefits in spinal muscular atrophy mice. Gene Therapy |
| Hammond SM, Abendroth F, Gait MJ, et al. (2019) Evaluation of Cell-Penetrating Peptide Delivery of Antisense Oligonucleotides for Therapeutic Efficacy in Spinal Muscular Atrophy. Methods in Molecular Biology (Clifton, N.J.). 2036: 221-236 |
| Gait MJ, Arzumanov AA, McClorey G, et al. (2018) Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment. Nucleic Acid Therapeutics |
| Betts CA, McClorey G, Healicon R, et al. (2018) Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment. Human Molecular Genetics |
| Walter LM, Deguise MO, Meijboom KE, et al. (2018) Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice. Ebiomedicine |
| Shabanpoor F, Hammond SM, Abendroth F, et al. (2017) Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy. Nucleic Acid Therapeutics |
| Hammond SM, Hazell G, Shabanpoor F, et al. (2016) Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy. Proceedings of the National Academy of Sciences of the United States of America |
| Betts CA, Saleh AF, Carr CA, et al. (2015) Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy. Scientific Reports. 5: 11632 |